Your browser doesn't support javascript.
loading
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma.
Laidlaw, Tanya M; Bachert, Claus; Amin, Nikhil; Desrosiers, Martin; Hellings, Peter W; Mullol, Joaquim; Maspero, Jorge F; Gevaert, Philippe; Zhang, Mei; Mao, Xuezhou; Khan, Asif H; Kamat, Siddhesh; Patel, Naimish; Graham, Neil M H; Ruddy, Marcella; Staudinger, Heribert; Mannent, Leda P.
Afiliación
  • Laidlaw TM; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: tlaidlaw@bwh.harvard.edu.
  • Bachert C; Department of Head & Skin, Upper Airways Research Laboratory, Faculty of Medicine, Ghent University, Ghent, Belgium; Division of Ear, Nose and Throat (ENT) Diseases, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
  • Amin N; Regeneron Pharmaceuticals Inc, Tarrytown, New York.
  • Desrosiers M; Department of Otolaryngology, Centre de recherche du Centre hospitalier de l'Université de Montreal (CRCHUM), Montreal, Quebec, Canada.
  • Hellings PW; Clinical Division of Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium.
  • Mullol J; Rhinology Unit & Smell Clinic, Department of Otorhinolaryngology, Hospital Clínic, The August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Universitat de Barcelona, Ciber De Enfermedades Respiratorias (CIBERES), Barcelona, Catalonia, Spain.
  • Maspero JF; Allergy and Respiratory Research Unit, Fundación CIDEA, Buenos Aires, Argentina.
  • Gevaert P; Department of Head & Skin, Upper Airways Research Laboratory, Faculty of Medicine, Ghent University, Ghent, Belgium.
  • Zhang M; Sanofi, Bridgewater, New Jersey.
  • Mao X; Sanofi, Bridgewater, New Jersey.
  • Khan AH; Sanofi, Chilly-Mazarin, France.
  • Kamat S; Regeneron Pharmaceuticals Inc, Tarrytown, New York.
  • Patel N; Sanofi, Cambridge, Massachusetts.
  • Graham NMH; Regeneron Pharmaceuticals Inc, Tarrytown, New York.
  • Ruddy M; Regeneron Pharmaceuticals Inc, Tarrytown, New York.
  • Staudinger H; Sanofi, Bridgewater, New Jersey.
  • Mannent LP; Sanofi, Chilly-Mazarin, France.
Ann Allergy Asthma Immunol ; 126(5): 584-592.e1, 2021 05.
Article en En | MEDLINE | ID: mdl-33465455
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Asma / Sinusitis / Rinitis / Pólipos Nasales / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Allergy Asthma Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Asma / Sinusitis / Rinitis / Pólipos Nasales / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Allergy Asthma Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article